Form 4 for TRDA Entrada Therapeutics, Inc.
Accepted 2022-06-29 00:00:00 ET · period of report 2022-06-27 · accession 0001104659-22-075788 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-06-29 | 2022-06-27 | TRDA | Dowden Nathan J | COO | S - Sale | $13.00 | -7,714 | 64.9K | -11% | -$100.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-27 | S | D | 7,714 | $13.00 | 64,893 | D | — | — |